NEW DELHI: More than 40 batches of drugs being sold in the market have been found to be not-of-standard quality (NSQ) by the Central Drug Standards Control Organisation (CDSCO) in latest survey.
The CDSCO, which is the apex body responsible for approval of new drugs and clinical trials, has issued an alert regarding this.
According to latest data, they found 41 batches of drugs manufactured by various firms to be of sub-standard quality in November.
This included some of the drugs prescribed for common conditions such as fever, acid reflux and reducing blood clot. Identification of drug samples as NSQ is done based on failure of the drug sample in one or the other specified quality parameters. The failure is specific to the drug products of the batch tested by govt, officials said. Recently, CDSCO introduced new guidelines for the inspections. It stated all drug inspectors in the country should collect at least 10 samples in a month; nine samples of drugs and one sample of cosmetics/medical device.